GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Clinical trial NCT05880043 · UNKNOWN

Trial details

NCT number: NCT05880043
Sponsor: GI Cell, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Relapsed/Refractory Non-Hodgkin Lymphoma Relapsed/Refractory Multiple Myeloma

Start date: 2023-04-28
Primary completion: 2025-12-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.